Sympathetic ophthalmia following vitrectomy for endophthalmitis after intravitreal bevacizumab

Ocul Immunol Inflamm. 2008 Sep-Oct;16(5):236-8. doi: 10.1080/09273940802409951.

Abstract

Purpose: To describe a case of sympathetic ophthalmia following vitrectomy for endophthalmitis after an intravitreal injection of bevacizumab.

Design: Retrospective case report.

Methods: An 84-year-old male developed sympathetic ophthalmia 4 months after vitrectomy for endophthalmitis following an intravitreal injection. The inciting blind eye was enucleated.

Results: Histopathology demonstrated sympathetic ophthalmia and phacoanaphylactic endophthalmitis. Visual acuity improved from 20/200 to 20/30 in the sympathizing eye with a combination of oral prednisone and azathioprine.

Conclusions: Sympathetic ophthalmia can develop following exogenous endophthalmitis but has a good visual prognosis with appropriate treatment.

Publication types

  • Case Reports

MeSH terms

  • Administration, Oral
  • Aged, 80 and over
  • Anti-Inflammatory Agents / administration & dosage
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Humanized
  • Azathioprine / administration & dosage
  • Bevacizumab
  • Drug Therapy, Combination
  • Endophthalmitis / surgery*
  • Eye Enucleation
  • Humans
  • Injections
  • Male
  • Ophthalmia, Sympathetic / etiology*
  • Ophthalmia, Sympathetic / pathology
  • Ophthalmia, Sympathetic / physiopathology
  • Ophthalmia, Sympathetic / surgery
  • Postoperative Complications*
  • Prednisone / administration & dosage
  • Retrospective Studies
  • Visual Acuity
  • Vitrectomy*
  • Vitreous Body*

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Azathioprine
  • Prednisone